Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse
about
Influenza virus antigenic variation, host antibody production and new approach to control epidemicsM2e-Based Universal Influenza A VaccinesVaccines: the Fourth CenturyInfluenza virus-like particles containing M2 induce broadly cross protective immunityUniversal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses.Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus.Novel vaccines against influenza viruses.Sublingual immunization with M2-based vaccine induces broad protective immunity against influenza.Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in miceProphylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.Vaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.In Vitro Evaluation of Influenza M2 and Leishmania major HSP70 (221-604) Chimer ProteinM2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.Mucosal vaccination with recombinant Lactobacillus casei-displayed CTA1-conjugated consensus matrix protein-2 (sM2) induces broad protection against divergent influenza subtypes in BALB/c mice.Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.An effective vaccination approach augments anti-HIV systemic and vaginal immunity in mice with decreased HIV-1 susceptible α4β7high CD4+ T cells.Virus-like particles containing the tetrameric ectodomain of influenza matrix protein 2 and flagellin induce heterosubtypic protection in mice.A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.Human influenza vaccines and assessment of immunogenicity.Immunological assessment of influenza vaccines and immune correlates of protection.Zymosan A enhances humoral immune responses to soluble protein in chickens.A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated Chickens.A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody.Intranasal Vaccination With Lipoproteins Confers Protection Against Pneumococcal Colonisation
P2860
Q21245119-1DF557EB-0F98-4D3F-B191-7A421572B18BQ26783493-585DBE97-81C2-4EAA-B9D8-E035B0303818Q27490454-E4EAF229-C4F8-46EC-88A1-A577802FAF4CQ28743472-C3BA394D-C972-4FE4-9E98-1E5EFA5DA145Q30375991-37CB533D-E10F-4974-BB6D-2E3A9B69795FQ30384563-35C87193-BAD3-4E07-BA6A-99D8183B99BCQ30397930-CC844790-F6A8-40B8-B828-C7EFF5CE88CBQ30407716-B971A647-4512-4A2C-84D7-0DB625207F66Q30410241-9B83C422-0F79-4CF3-9708-31EEE28BEDD2Q30428969-0D4A7CA8-A958-4CD6-8D91-15435D3ABF78Q33676552-164EB8DB-2015-4542-A99D-DE8F443AA778Q34105207-F1F4DF07-FE0B-4FAA-850C-9E07FCC86C7FQ34430020-EE18B3E7-9115-48D8-BB65-17F0E6F39280Q34629573-2FCAB3CF-EF4E-4165-A617-A3CF4F8D0D2FQ34634610-36C8936B-E9B3-4E88-9E60-4743AE148F82Q35142923-9DBD9055-D0C3-4CEE-A2B9-38138412CC19Q35209148-6CAFB098-009E-47E1-955B-EC52D6CC7B69Q37030417-5DB3AD89-071B-4AFC-A3A3-AD74760B1607Q37101184-AE808026-1C39-4EEC-96D9-E7CE913C888AQ37547653-DDD91F5C-3080-49DA-B3A5-231078179012Q37627859-557E4B3A-76C0-431E-A15D-2EB49F6B20B2Q37812125-10363FE2-6109-4FDD-8797-5AF3980263FDQ38105339-5D8620BD-73C9-4A04-B8BE-01958D9744FBQ40157097-98ABC45D-34DE-46B8-87D4-53C471207837Q41839546-3470F1CB-2BEF-4482-9677-6041CB5C68DFQ43153414-22BB0FE5-90B3-4E75-A138-7E43CAF5B459Q58596157-2A2135BB-7080-4E04-81A1-E17293558D18
P2860
Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Roles of adjuvant and route of ...... a A virus vaccine in the mouse
@ast
Roles of adjuvant and route of ...... a A virus vaccine in the mouse
@en
type
label
Roles of adjuvant and route of ...... a A virus vaccine in the mouse
@ast
Roles of adjuvant and route of ...... a A virus vaccine in the mouse
@en
prefLabel
Roles of adjuvant and route of ...... a A virus vaccine in the mouse
@ast
Roles of adjuvant and route of ...... a A virus vaccine in the mouse
@en
P2093
P2860
P356
P1433
P1476
Roles of adjuvant and route of ...... a A virus vaccine in the mouse
@en
P2093
Darya Zharikova
Krystyna Mozdzanowska
Laszlo Otvos
Mare Cudic
Walter Gerhard
P2860
P356
10.1186/1743-422X-4-118
P577
2007-10-31T00:00:00Z